You are here: Industry Insights > DEA

News List

NewsPoints Former DEA official helped pharma company get drug quota increase, says watchdog FirstWordPharma
December 03, 2021
According to the US Justice Department's internal watchdog, a former senior official at the Drug Enforcement Administration (DEA) improperly gave preferential treatment to a pharmaceutical company that was seeking a quota increase so it could...
Neusoft Medical has reached a strategic cooperation of Sino-Pakistan Healthcare in Pakistan prnasia
December 25, 2020
Neusoft Medical Systems Co., Ltd. (Neusoft Medical) announced the cloud signing of a memorandum of understanding (MOU) with Dynamic Engineering and Automation Group (DEA) to cooperate in the area of healthcare in Pakistan.
DEA to Approve Dozens More Growers for Marijuana Research drugs
August 28, 2019
The number of marijuana growers allowed to produce the drug for U.S. government-approved research will be expanded from one to 34, officials say.
Particle Sciences Expands Controlled Substance Capabilities contractpharma
May 30, 2019
Receives approval of DEA Schedule I registration.
Epidiolex Placed In Schedule V of Controlled Substance Act americanpharmaceuticalreview
September 29, 2018
The Department of Justice and Drug Enforcement Administration (DEA) has announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedu
DEA gives some of Pfizer's injected narcotics allotment to competitors as production issues intensify shortages fiercepharma
May 28, 2018
Pfizer, the largest U.S. producer of injected narcotics, said Wednesday it has resumed production of some of the prefilled syringes that have been in short supply and expects to have the first shipments to wholesalers in July.